Mar 22, 2024
1:7
For every 7 shares held, investors received 1. The price per share adjusted from $2.31 to $0.33.
The split itself did not change the total investment value.
LENZ Therapeutics, Inc. (LENZ) trades on the NASDAQ Global Select in the Biotechnology industry.
LENZ Therapeutics, Inc. company overviewThe latest split shown was on March 22, 2024. It was a 1-for-7 reverse split, so shareholders received 1 share for every 7 they held.
This history records one reverse split, on March 22, 2024.